Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
RESEARCH TOOLSreports
Holding APGE?
Track your performance easily
APGE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.19 - $72.29
Previous Close$54.49
Volume466.68K
Average Volume (3M)386.96K
Market Cap
$3.19B
Enterprise Value$2.51B
Total Cash (Recent Filing)$676.23M
Total Debt (Recent Filing)$4.08M
Price to Earnings (P/E)―
Beta2.01
Next Earnings
Nov 11, 2024EPS Estimate
-$0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.27
Shares Outstanding58,485,705
10 Day Avg. Volume260,294
30 Day Avg. Volume386,960
Standard Deviation0.29
R-Squared0.15
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)4.12
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-26.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-24.40
Forecast
1Y Price Target
$89.00Price Target Upside63.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Apogee Therapeutics, Inc. News
PremiumCompany Announcements
Apogee Therapeutics Unveils Promising Phase 1 Trial Results
PremiumCompany Announcements
Apogee Therapeutics Begins Landmark Atopic Dermatitis Trial
Ownership Overview
12.73% Insiders
28.01% Mutual Funds
1.44% Other Institutional Investors
46.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
APGE FAQ
What was Apogee Therapeutics, Inc.’s price range in the past 12 months?
Apogee Therapeutics, Inc. lowest stock price was $14.19 and its highest was $72.29 in the past 12 months.
What is Apogee Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Apogee Therapeutics, Inc.’s upcoming earnings report date?
Apogee Therapeutics, Inc.’s upcoming earnings report date is Nov 11, 2024 which is in 9 days.
How were Apogee Therapeutics, Inc.’s earnings last quarter?
Apogee Therapeutics, Inc. released its earnings results on Aug 12, 2024. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.598 by -$0.002.
Is Apogee Therapeutics, Inc. overvalued?
According to Wall Street analysts Apogee Therapeutics, Inc.’s price is currently Undervalued.
Does Apogee Therapeutics, Inc. pay dividends?
Apogee Therapeutics, Inc. does not currently pay dividends.
What is Apogee Therapeutics, Inc.’s EPS estimate?
Apogee Therapeutics, Inc.’s EPS estimate is -$0.78.
How many shares outstanding does Apogee Therapeutics, Inc. have?
Apogee Therapeutics, Inc. has 44,999,060 shares outstanding.
What happened to Apogee Therapeutics, Inc.’s price movement after its last earnings report?
Apogee Therapeutics, Inc. reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.598. Following the earnings report the stock price went up 9.778%.
Which hedge fund is a major shareholder of Apogee Therapeutics, Inc.?
Among the largest hedge funds holding Apogee Therapeutics, Inc.’s share is Driehaus Capital Management LLC. It holds Apogee Therapeutics, Inc.’s shares valued at 83M.
---
Apogee Therapeutics, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$89.00 (63.33% Upside)
$89.00 (63.33% Upside)
Blogger Sentiment
Bullish
APGE Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 989.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $289.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
203.90%
12-Months-Change
Fundamentals
Return on Equity
-26.73%
Trailing 12-Months
Asset Growth
512.75%
Trailing 12-Months
Company Description
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
---
APGE Stock 12 Month Forecast
Average Price Target
$89.00
▲(63.33% Upside)
Technical Analysis
Best Analysts Covering APGE
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+50.58%
reiterated a buy rating 8 months ago
Copying Alex Thompson CFA's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +50.58% per trade.
---